The company has increased manufacturing capacity from pilot scale to 1 million liters annually, and can now assist customers ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

Despite not having the legal authority to enact the change, President Trump signs an executive order asking drug companies to ...

Regeneron's lead counsel was Jonathan D. Polkes of White & Case LLP.

Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

Money flows out of Harvard into biotechs, housing projects, and retail storefronts. The school powers hospitals, tourism, and ...

Biowave will address this lackluster entrepreneurial activity and bring more VC investment into India’s life sciences.

First Commercial Sales: Humacyte commenced its commercial launch of Symvess in late February 2025 after the first commercial batch was released by the FDA. The first commercial shipments containing ...

In terms of what constitutes a company of concern, the main focus is Chinese biotechnology companies ... President Donald Trump said he will sign an order today to cut prescription drug prices ...

The aim of the act will be to simplify the regulations governing biotech companies and projects, viewed as an impediment to investment in the EU. It will also improve access to financing for start ...

The Swiss biotech company Roche announced on Monday plans ... the state’s Health First initiative. There were warning signs that lawmakers were looking towards restrictions on the program ...